Literature DB >> 19450797

Clostridium difficile in hip fracture patients: prevention, treatment and associated mortality.

Abhinav Gulihar1, Matthew Nixon, David Jenkins, Grahame J S Taylor.   

Abstract

BACKGROUND: A series of infection control measures were introduced at the University Hospitals of Leicester NHS Trust in 2006-2007 to reduce the incidence of Clostridium difficile infection. AIM: The aim of this study was to assess the impact of these measures on the incidence of C. difficile and to record the associated mortality in hip fracture patients. PATIENTS AND METHODS: A case matched comparison of mortality was conducted between C. difficile positive patients and C. difficile negative patients admitted with a hip fracture between 1st January 2003 and 30th September 2007. An interrupted time series analysis was performed to assess the effect of various infection control policies on the incidence of C. difficile infection.
RESULTS: The interrupted time series analysis showed that the only effective measure was changing antimicrobial prophylaxis to Co-amoxiclav in May 2007. This reduced the incidence of C. difficile from 7.1 to 1.5% (p<0.001). Six-month mortality in C. difficile positive patients was 71% 1 year before introduction of a diarrhoea treatment policy and 65% 1 year after (p=0.5) indicating treatment was ineffective. A matched cohort comparison over a 57-month period from January 2003 to September 2007 showed that the 6-month mortality was 67% in 170 C. difficile positive patients, 27% in 3247 C. difficile negative patients and 29% in the 170 C. difficile negative matched patients.
CONCLUSION: This 38% excess mortality indicated that C. difficile increased mortality and did not simply colonise the sickest patients. Changing prophylaxis to Co-amoxiclav was the most effective measure. This reduced the incidence of C. difficile by 80% and thus reduced mortality by prevention rather than cure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19450797     DOI: 10.1016/j.injury.2008.12.004

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  9 in total

1.  Prophylactic use of gentamicin/flucloxacillin versus cefuroxime in surgery: a meta analysis of clinical studies.

Authors:  Shaoning Luo; Yu Lai; Chunxin Liu; Yi Chen; Xiaoyu Qiao
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 2.  Reducing Clostridium difficile in the Inpatient Setting: A Systematic Review of the Adherence to and Effectiveness of C. difficile Prevention Bundles.

Authors:  Anna K Barker; Caitlyn Ngam; Jackson S Musuuza; Valerie M Vaughn; Nasia Safdar
Journal:  Infect Control Hosp Epidemiol       Date:  2017-03-27       Impact factor: 3.254

3.  Editor's Spotlight/Take 5: How Common-and How Serious-Is Clostridium difficile Colitis After Geriatric Hip Fracture? Findings from the NSQIP Dataset.

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

4.  Probiotics improve bowel movements in hospitalized elderly patients--the PROAGE study.

Authors:  H Zaharoni; E Rimon; H Vardi; M Friger; A Bolotin; D R Shahar
Journal:  J Nutr Health Aging       Date:  2011-03       Impact factor: 4.075

5.  How Common-and How Serious- Is Clostridium difficile Colitis After Geriatric Hip Fracture? Findings from the NSQIP Dataset.

Authors:  Patawut Bovonratwet; Daniel D Bohl; Glenn S Russo; Nathaniel T Ondeck; Denis Nam; Craig J Della Valle; Jonathan N Grauer
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

6.  Management of a cluster of Clostridium difficile infections among patients with osteoarticular infections.

Authors:  Jacqueline Färber; Sebastian Illiger; Fabian Berger; Barbara Gärtner; Lutz von Müller; Christoph H Lohmann; Katja Bauer; Christina Grabau; Stefanie Zibolka; Dirk Schlüter; Gernot Geginat
Journal:  Antimicrob Resist Infect Control       Date:  2017-02-15       Impact factor: 4.887

7.  Mortality and Clostridium difficile infection: a review.

Authors:  Brett G Mitchell; Anne Gardner
Journal:  Antimicrob Resist Infect Control       Date:  2012-05-30       Impact factor: 4.887

Review 8.  Patient and system factors of mortality after hip fracture: a scoping review.

Authors:  K J Sheehan; B Sobolev; A Chudyk; T Stephens; P Guy
Journal:  BMC Musculoskelet Disord       Date:  2016-04-14       Impact factor: 2.362

9.  Use of interrupted time series methods in the evaluation of health system quality improvement interventions: a methodological systematic review.

Authors:  Celestin Hategeka; Hinda Ruton; Mohammad Karamouzian; Larry D Lynd; Michael R Law
Journal:  BMJ Glob Health       Date:  2020-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.